Cabaletta Bio, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Cabaletta Bio, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2021-12-31	2020-12-31	2019-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$172.24M	-$125.14M	-$46.31M	-$33.83M	-$18.68M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$167.86M	-$115.86M	-$46.29M	-$33.34M	-$16.94M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-2.00	$-2.00	$-1.80	$-1.44	$-4.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-2.00	$-2.00	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2021-12-31	2020-12-31	2019-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$82.98M	$163.96M	$122.22M	$101.43M	$136.20M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$165.08M	$185.05M	$126.34M	–	$141.47M
Everything the company owes — debt, unpaid bills, and other obligations.	$53.03M	$32.71M	–	–	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$112.05M	$152.34M	$117.96M	–	$138.32M

Cash Flow Statement

	2025-12-31	2024-12-31	2021-12-31	2020-12-31	2019-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$131.08M	-$88.22M	-$34.11M	-$26.77M	-$16.05M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$1.23M	$2.21M	$1.17M	$635000	$693000
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$132.31M	-$90.43M	-$35.27M	-$27.41M	-$16.74M